Home » Topics » Regulatory » Patents

Patents
RSS

HMR discloses 5-HT reuptake inhibitors

May 24, 1996

New contraceptives reported by Akzo Nobel

May 24, 1996

Takeda claims antidiabetic and hypolipidemic agents

May 24, 1996

Role of p140 in diabetes investigated by Ono

May 24, 1996

Nitto Boseki claims serine protease inhibitors

May 24, 1996

Tobishi CCK-A antagonists for pancreatitis

May 24, 1996

Sankyo reports 5alpha-reductase inhibitors for BPH

May 24, 1996

Fibrinogen antagonists claimed by Taisho

May 24, 1996

Mitsui Toatsu reports bicyclic fibrinogen antagonists

May 24, 1996

E. Merck claims oxazolidinone adhesion receptor antagonists

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.